HEADER ANTIBIOTIC 18-MAR-14 2MMT TITLE LASSO PEPTIDE-BASED INTEGRIN INHIBITOR: MICROCIN J25 VARIANT WITH RGDF TITLE 2 SUBSTITUTION OF GLY12-ILE13-GLY14-THR15 COMPND MOL_ID: 1; COMPND 2 MOLECULE: MICROCIN J25 RGDF MUTANT; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 38-58; COMPND 5 SYNONYM: MCCJ25(RGDF); COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 ORGANISM_SCIENTIFIC: ESCHERICHIA COLI; SOURCE 4 ORGANISM_TAXID: 562 KEYWDS LASSO PEPTIDE, EPITOPE GRAFTING, INTEGRIN INHIBITOR, DRUG DESIGN, KEYWDS 2 MOLECULAR SCAFFOLDS, MOLECULAR DYNAMICS, ANTIBIOTIC EXPDTA SOLUTION NMR NUMMDL 15 AUTHOR J.D.HEGEMANN,M.ZIMMERMANN,T.A.KNAPPE,X.XIE,M.A.MARAHIEL REVDAT 3 06-NOV-24 2MMT 1 REMARK SEQADV LINK REVDAT 2 23-JUL-14 2MMT 1 JRNL REVDAT 1 02-JUL-14 2MMT 0 JRNL AUTH J.D.HEGEMANN,M.DE SIMONE,M.ZIMMERMANN,T.A.KNAPPE,X.XIE, JRNL AUTH 2 F.S.DI LEVA,L.MARINELLI,E.NOVELLINO,S.ZAHLER,H.KESSLER, JRNL AUTH 3 M.A.MARAHIEL JRNL TITL RATIONAL IMPROVEMENT OF THE AFFINITY AND SELECTIVITY OF JRNL TITL 2 INTEGRIN BINDING OF GRAFTED LASSO PEPTIDES. JRNL REF J.MED.CHEM. V. 57 5829 2014 JRNL REFN ISSN 0022-2623 JRNL PMID 24949551 JRNL DOI 10.1021/JM5004478 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CYANA 2.1 REMARK 3 AUTHORS : GUNTERT, MUMENTHALER REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2MMT COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 21-MAR-14. REMARK 100 THE DEPOSITION ID IS D_1000103802. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : NULL REMARK 210 IONIC STRENGTH : NULL REMARK 210 PRESSURE : 1.0 ATM REMARK 210 SAMPLE CONTENTS : 12.6 MM MCCJ25(RGDF), METHANOL REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D DQF-COSY; 2D 1H-1H TOCSY; 2D REMARK 210 1H-1H NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NULL REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 50 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 15 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 ARG A 12 29.51 -76.74 REMARK 500 1 ASP A 14 -76.10 -116.11 REMARK 500 2 ARG A 12 29.41 -76.92 REMARK 500 2 ASP A 14 -76.24 -115.96 REMARK 500 2 ILE A 17 -64.41 -103.10 REMARK 500 3 ALA A 3 42.04 -108.20 REMARK 500 3 ARG A 12 29.91 -76.83 REMARK 500 3 ASP A 14 -75.34 -116.26 REMARK 500 3 ILE A 17 -64.54 -102.86 REMARK 500 3 TYR A 20 -178.36 -69.39 REMARK 500 4 ALA A 3 43.49 -108.61 REMARK 500 4 ARG A 12 29.36 -77.06 REMARK 500 4 ASP A 14 -75.74 -116.10 REMARK 500 4 ILE A 17 -64.88 -102.39 REMARK 500 5 ARG A 12 25.10 -77.23 REMARK 500 5 ASP A 14 -76.43 -116.06 REMARK 500 5 ILE A 17 -64.69 -102.07 REMARK 500 6 ARG A 12 26.23 -76.97 REMARK 500 6 ASP A 14 -76.09 -116.27 REMARK 500 6 ILE A 17 -63.98 -100.64 REMARK 500 7 ALA A 3 45.44 -105.20 REMARK 500 7 ARG A 12 25.68 -77.16 REMARK 500 7 ASP A 14 -76.22 -116.18 REMARK 500 7 TYR A 20 -174.24 -68.77 REMARK 500 8 ARG A 12 25.16 -77.25 REMARK 500 8 ASP A 14 -76.63 -116.10 REMARK 500 8 ILE A 17 -63.67 -108.36 REMARK 500 9 ARG A 12 25.30 -77.21 REMARK 500 9 ASP A 14 -76.24 -116.24 REMARK 500 10 ARG A 12 25.15 -77.47 REMARK 500 10 ASP A 14 -76.18 -116.13 REMARK 500 10 ILE A 17 -61.27 -105.64 REMARK 500 11 ARG A 12 29.64 -76.64 REMARK 500 11 ASP A 14 -75.49 -116.10 REMARK 500 11 ILE A 17 -60.57 -107.35 REMARK 500 12 ARG A 12 25.85 -76.83 REMARK 500 12 ASP A 14 -76.20 -116.30 REMARK 500 13 ARG A 12 25.78 -76.88 REMARK 500 13 ASP A 14 -76.24 -116.15 REMARK 500 13 ILE A 17 -61.75 -100.00 REMARK 500 14 ARG A 12 25.82 -77.20 REMARK 500 14 ASP A 14 -76.00 -116.25 REMARK 500 15 ALA A 3 43.22 -107.39 REMARK 500 15 ARG A 12 25.71 -76.90 REMARK 500 15 ASP A 14 -76.15 -116.06 REMARK 500 15 ILE A 17 -62.95 -107.80 REMARK 500 15 TYR A 20 -177.09 -67.77 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 19865 RELATED DB: BMRB DBREF 2MMT A 1 21 UNP Q9X2V7 MCJA_ECOLX 38 58 SEQADV 2MMT ARG A 12 UNP Q9X2V7 GLY 49 ENGINEERED MUTATION SEQADV 2MMT GLY A 13 UNP Q9X2V7 ILE 50 ENGINEERED MUTATION SEQADV 2MMT ASP A 14 UNP Q9X2V7 GLY 51 ENGINEERED MUTATION SEQADV 2MMT PHE A 15 UNP Q9X2V7 THR 52 ENGINEERED MUTATION SEQRES 1 A 21 GLY GLY ALA GLY HIS VAL PRO GLU TYR PHE VAL ARG GLY SEQRES 2 A 21 ASP PHE PRO ILE SER PHE TYR GLY LINK N GLY A 1 CD GLU A 8 1555 1555 1.35 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1